David Tulasne

3.3k citations

73 papers · 2.4k indexed · h-index 32

Impact in

Hepatology top 1%
- Liver physiology and pathology
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research

Papers in

Hepatology 38
- Liver physiology and pathology 37
Immunology and Allergy 7
- Cell Adhesion Molecules Research 7

Co-authors: Catherine Leroy Véronique Fafeur Bénédicte Foveau Steve P. Watson Zoulika Kherrouche Alexis B. Cortot Michael C. Berndt J Lefèbvre
Journals: Journal of Biological Chemistry (5 papers)Journal of Thoracic Oncology (4 papers)Cell Death and Disease (4 papers)Cell Death and Differentiation (4 papers)Oncogene (4 papers)
Partner nations: France United States United Kingdom

In The Last Decade

David Tulasne

71 papers receiving 2.4k citations

Peers

Countries citing papers authored by David Tulasne

Since Specialization

Citations

This map shows the geographic impact of David Tulasne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tulasne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tulasne more than expected).

Fields of papers citing papers by David Tulasne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tulasne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tulasne. The network helps show where David Tulasne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Tulasne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Tulasne Line = papers co-authored together David Tulasne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive map of the regulatory network triggered by MET exon 14 skipping reveals important involvement of the RAS-ERK signaling pathway Cell Death and Disease ·Marie‐José Truong, 昊婧刘, Emeric Vuillemin, Shéhérazade Sebda, Marie Fernandes, سعد رفعت سرحت, Mohamed Elati, David Tulasne	2025	0
2	High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study Journal of Thoracic Oncology ·Simon Baldacci, Martin Figeac, Martine Antoine, 高野優香, Zoulika Kherrouche, Philippe Jamme, Marie‐Christine Copin, David Tulasne, Isabelle Nanni, Michèle Beau‐Faller, Samia Melaabi, Guénaëlle Levallet, Élisabeth Quoix, Denis Moro‐Sibilot, S. Friard, Pascale Missy, Fabrice Barlési, Jacques Cadranel, Alexis B. Cortot	2019	16
3	Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes Scientific Reports ·محمد عموزاده عمرانی, 徳橋泰明, Orvin A. Lobitos, Catherine Leroy, Erick Delenia, David Tulasne, Gard Granerød, Vincent Jung, Ida Chiara Guerrera, Sabrina Marion, Jamal Khalife, Christine Pierrot	2019	8
4	Premature termination codon readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins Journal of Cell Science ·Jieshuang Jia, Elisabeth Werkmeister, Sara Gonzalez-Hilarion, Catherine Leroy, Dieter C. Gruenert, Frank Lafont, David Tulasne, Fabrice Lejeune	2017	16
5	Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis Journal of Biological Chemistry ·Catherine Leroy, Natalya V. Belkina, Thavy Long, Emeric Deruy, Colette Dissous, Stephen Shaw, David Tulasne	2016	10
6	Inhibition du récepteur MET : un espoir dans la lutte contre les résistances aux thérapies ciblées ? Bulletin du Cancer ·田中アツ, Pierre Leblond, Xuefen Le Bourhis, Samuel Meignan, David Tulasne	2016	6
7	Caspases shutdown nonsense-mediated mRNA decay during apoptosis Cell Death and Differentiation ·Jieshuang Jia, Alessandro Furlan, Sara Gonzalez-Hilarion, Catherine Leroy, Dieter C. Gruenert, David Tulasne, Fabrice Lejeune	2015	38
8	PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met‐addicted tumor cells Molecular Oncology ·Zoulika Kherrouche, Didier Monté, Elisabeth Werkmeister, Helen Gildfind, Yvan de Launoit, Alexis B. Cortot, David Tulasne, Anne Chotteau‐Lelièvre	2015	24
9	Le récepteur Met fête ses 30 ans médecine/sciences ·Rémi Montagne, Alessandro Furlan, Zoulika Kherrouche, David Tulasne	2014	6
10	Tensin-4-Dependent MET Stabilization Is Essential for Survival and Proliferation in Carcinoma Cells Developmental Cell ·Ghaffar Muharram, Pranshu Sahgal, Jean-Michel Foissy, Nicola De Franceschi, Riina Kaukonen, Katherine Clark, David Tulasne, Olli Carpén, Johanna Ivaska	2014	61
11	Loss of a Negative Feedback Loop Involving Pea3 and Cyclin D2 Is Required for Pea3-Induced Migration in Transformed Mammary Epithelial Cells Molecular Cancer Research ·Franck Ladam, Carmen Antonia Rodríguez-Herrera, Patrick Dumont, Zoulika Kherrouche, Yvan de Launoit, David Tulasne, Anne Chotteau‐Lelièvre	2013	12
12	The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase Glycobiology ·Aurélie Cazet, Marie Bobowski, Yoann Rombouts, J Lefèbvre, Agata Steenackers, Iuliana Popa, Yann Guérardel, Xuefen Le Bourhis, David Tulasne, Philippe Delannoy	2012	80
13	Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cells Comptes Rendus Chimie ·Agata Steenackers, Aurélie Cazet, Marie Bobowski, Yoann Rombouts, J Lefèbvre, Yann Guérardel, David Tulasne, Xuefen Le Bourhis, Philippe Delannoy	2011	6
14	Molecular cloning and characterisation of SmSLK, a novel Ste20-like kinase in Schistosoma mansoni International Journal for Parasitology ·Yutao Yan, David Tulasne, Edith Browaeys, Katia Cailliau, N. Khayath, Raymond J. Pierce, Jacques Trolet, Véronique Fafeur, Aména Ben Younes, Colette Dissous	2007	16
15	The Fc receptor γ‐chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C‐type lectin, convulxin European Journal of Biochemistry ·Oscar Berlanga, David Tulasne, Hans Bakker, Daniel Snell, Yoshiki Miura, Stéphanie Jung, Masaaki Moroi, Jonathan Frampton, Steve P. Watson	2002	41
16	Involvement of RAS‐ERK Signaling in Multiple Biological Responses to HGF/SF Annals of the New York Academy of Sciences ·David Tulasne, Réjane Paumelle, Catherine Leroy, Sylvie Reveneau, Bernard Vandenbunder, Véronique Fafeur	2002	4
17	Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling Journal of Biological Chemistry ·Katsue Suzuki‐Inoue, David Tulasne, Yang Shen, 梓荃, Osamu Inoue, Stéphanie Jung, Masaaki Moroi, Robert K. Andrews, Michael C. Berndt, Steve P. Watson	2002	127
18	A Novel Viper Venom Metalloproteinase, Alborhagin, Is an Agonist at the Platelet Collagen Receptor GPVI Journal of Biological Chemistry ·Robert K. Andrews, Elizabeth E. Gardiner, Naoki Asazuma, Oscar Berlanga, David Tulasne, Bernhard Nieswandt, A. Ian Smith, Michael C. Berndt, Steve P. Watson	2001	54
19	Sequential Activation of ERK and Repression of JNK by Scatter Factor/Hepatocyte Growth Factor in Madin-Darby Canine Kidney Epithelial Cells Molecular Biology of the Cell ·Réjane Paumelle, David Tulasne, Catherine Leroy, Jean Coll, Bernard Vandenbunder, Véronique Fafeur	2000	60
20	The Multisubstrate Docking Site of the MET Receptor Is Dispensable for MET-mediated RAS Signaling and Cell Scattering Molecular Biology of the Cell ·David Tulasne, Réjane Paumelle, K. Michael Weidner, Bernard Vandenbunder, Véronique Fafeur	1999	60

About David Tulasne

David Tulasne is a scholar working on Hepatology, Immunology and Allergy, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 73 papers that have together received 2.4k indexed citations. Recurring topics across this work include Liver physiology and pathology (37 papers), PI3K/AKT/mTOR signaling in cancer (18 papers), Lung Cancer Treatments and Mutations (14 papers), Cell death mechanisms and regulation (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Cell Adhesion Molecules Research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Hepatology (545 citations), Immunology and Allergy (224 citations), Hematology (404 citations), Molecular Biology (1.3k citations) and Cancer Research (271 citations). David Tulasne has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Catherine Leroy, Véronique Fafeur, Bénédicte Foveau, Steve P. Watson, Zoulika Kherrouche, Alexis B. Cortot, Michael C. Berndt, J Lefèbvre, Alessandro Furlan and Robert K. Andrews. Their work appears in journals such as Journal of Biological Chemistry, Journal of Thoracic Oncology, Cell Death and Disease, Cell Death and Differentiation and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact